Literature DB >> 6432387

Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome.

T H Bacon, F Ozbakir, C A Elms, A M Denman.   

Abstract

Interferon-gamma (IFN-gamma) production by peripheral blood mononuclear cells (MNC) from patients with Behçet's syndrome was compared with production by MNC from control donors. There was no evidence of significant spontaneous production of either IFN-gamma or interferon-alpha (IFN-alpha) by unstimulated MNC from patients or controls but phytohaemagglutinin treatment of MNC induced IFN-gamma in both patient and control groups. Significantly higher titres of IFN-gamma were produced by MNC from patients with Behçet's syndrome than MNC from patients with other inflammatory diseases (P = 0.005), hospital controls (P = 0.036) or healthy controls (P = 0.009). No IFN was detected in plasma from patients or controls.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432387      PMCID: PMC1536254     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Behçet's syndrome with arthritis.

Authors:  R M Mason; C G Barnes
Journal:  Ann Rheum Dis       Date:  1969-03       Impact factor: 19.103

2.  Establishment of human cell lines constitutively producing immune interferon: transformation of normal T cells by a human retrovirus.

Authors:  K Sugamura; M Matsuyama; M Fujii; M Kannagi; Y Hinuma
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

3.  Lymphocyte responses in juvenile chronic arthritis and Behçet's disease--cell number requirements and effects of glucocorticosteroid therapy.

Authors:  A de Vere-Tyndall; S Knight; S Burman; A M Denman; B M Ansell
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

4.  Spontaneous production of interferon-gamma and acid-labile interferon-alpha by subpopulations of human mononuclear cells.

Authors:  D G Fischer; M Rubinstein
Journal:  Cell Immunol       Date:  1983-10-15       Impact factor: 4.868

5.  Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies.

Authors:  T H Bacon; A de Vere-Tyndall; D A Tyrrell; A M Denman; B M Ansell
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

6.  Strain variation in interferon gamma production of BCG-sensitized mice challenged with PPD. I. CBA/Ca mice are low producers in vivo, but high producers in vitro.

Authors:  K Huygen; K Palfliet
Journal:  Cell Immunol       Date:  1983-09       Impact factor: 4.868

7.  Immune interferon in the circulation of patients with autoimmune disease.

Authors:  J J Hooks; H M Moutsopoulos; S A Geis; N I Stahl; J L Decker; A L Notkins
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

8.  Spontaneous production of gamma-interferon in cultures of T lymphocytes obtained from patients with Behçet's disease.

Authors:  N Fujii; T Minagawa; A Nakane; F Kato; S Ohno
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

9.  Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.

Authors:  G H Wong; I Clark-Lewis; L McKimm-Breschkin; A W Harris; J W Schrader
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.

Authors:  O T Preble; K Rothko; J H Klippel; R M Friedman; M I Johnston
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  7 in total

1.  Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?

Authors:  U Musabak; S Pay; H Erdem; I Simsek; A Pekel; A Dinc; A Sengul
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

2.  Cytotoxic T cells against herpes simplex virus in Behçet's disease.

Authors:  K Hamzaoui; A Kahan; K Ayed; M Hamza
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

3.  Natural killer cells in Behçet's disease.

Authors:  K Hamzaoui; K Ayed; M Hamza; J L Touraine
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

4.  Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease.

Authors:  K Hamzaoui; K Ayed; A Slim; M Hamza; J Touraine
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

5.  CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease.

Authors:  C Young; T Lehner; C G Barnes
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

6.  2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases.

Authors:  W Hylton; J Cayley; C Dore; A M Denman
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

7.  Interleukin-6 in peripheral blood and inflammatory sites in Behçet's disease.

Authors:  K Hamzaoui; A Hamzaoui; A Kahan; M Hamza; A Chabbou; K Ayed
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.